The islanders will walk the footsteps of aboriginals and natives in the displacement. But this will not win over the hardcore pink IC silver serpents with their families who have been receiving pay raise and bonuses every year sitting in their iron-bowl jobs. Dont even talk about being a democratic island or democratic country next time. Our pledge clearly reminded every citizens that this island is 'TO BUILD A DEMOCRATIC SOCIETY' - to build, NOT YET, have not been a democratic society still. When PSP talk and remind the parliament on 'Democracy', I think he totally forgotten the Pledge that we have to recite religiously once (at least) every year on National Day (despite who is the ruling party). Of course this is the TOP KPI and priority to them over anything else. Maccecchini noted that additional trial data, such as the treatment’s effect on biological markers of disease activity, are still being analyzed, and will be presented at a later date.Įarlier interim trial data also supported the treatment’s safety at a dose of 80 mg once a day.PSP ask the parliament members on why the priority is on 'Economic Growth'? This is the only thing that justify their high salaries, high bonuses - together with the silver serpents. “These positive efficacy results, which expand on our previous data from AD and PD patients, add clarity to the benefits that ANVS401 may offer to patients suffering from these chronic neurodegenerative diseases,” she added. “Through examination of this dose-response, we can determine an optimal safe and efficacious dose as we move forward towards initiation of Phase 3 clinical trials with much larger patient populations and longer timelines,” Maccecchini said. These results, overall, indicate that the treatment was effective at the doses tested, hinting that the highest efficacy may be seen at doses of around 10 or 20 mg a day, Annovis stated.

This covers a wide enough range of intellectual assessment for most clinical applications.

Significant gains from baseline were also recorded among patients given ANVS40 at 10 or 20 mg on the MDS-UPDRS overall score, as well as on several subscales of this comprehensive measure. The WAIS-IV FSIQ ranges from 40160 (±4 SD) and represents a 2/3 SD increase in IQ measurement range over the WAIS-III.

Specific WAIS score improvements indicated better motor dexterity, and more speed and accuracy in completing the assessment. Additionally, WAIS scores in these patients were significantly higher at the study’s end (25 days) than they had been at its start (baseline measures). The medication’s efficacy was measured based on scores of the Wechsler Adult Intelligence Scale coding test (WAIS), a measure of cognitive abilities in adults, and the MDS-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), a disease-specific measure of Parkinson’s severity.Ĭompared to patients on a placebo capsule, those given ANVS401 at doses of 5, 20, or 80 mg showed significant improvements on WAIS scores.

Wais 4